|
N/A
|
ACN12001-001
|
$270
|
$270
|
-, -
|
NASA/JPL JET PROPULSION LABORA
|
|
(9) Biophysical Description of Age and Dose Dependent Changes to Dendritic Morphology that Impact Cognition following Radiation Cancer Therapy
|
5R01CA208526-03
|
$472,047
|
$472,047
|
CUCINOTTA, FRANCIS
|
UNIVERSITY OF NEVADA LAS VEGAS
|
|
(9) Therapeutic strategies to mitigate toxicities of platinum-based therapeutics
|
5R01CA215802-02
|
$511,546
|
$511,546
|
SPARREBOOM, ALEXANDER
|
OHIO STATE UNIVERSITY
|
|
(PQ #8) Biomarkers of efficacy and adverse events due to treatment with immune checkpoint inhibitors
|
1R01CA231291-01
|
$533,211
|
$533,211
|
WELLSTEIN, ANTON
|
GEORGETOWN UNIVERSITY
|
|
(PQ 12) Targeting SMPDL3b to Prevent Radiation-Induced Nephrotoxicity
|
1R01CA227493-01
|
$427,990
|
$427,990
|
MARPLES, BRIAN
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
(PQ 5) Roles of mitochondrial heterogeneity in cell survival and oncogenesis
|
5R21CA216304-02
|
$195,750
|
$195,750
|
NEWMEYER, DONALD
|
LA JOLLA INST FOR ALLERGY & IMMUNOLGY
|
|
(PQ#3) Novel tumor intrinsic PD-L1 signals direct tumor immune cell infiltration
|
5R01CA205965-02
|
$640,839
|
$640,839
|
CURIEL, TYLER
|
UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
|
|
(PQ#9) Promoting Axon Stability to Prevent Therapy-induced Peripheral Neuropathy
|
5R01CA219866-02
|
$465,400
|
$465,400
|
DIANTONIO, AARON
|
WASHINGTON UNIVERSITY
|
|
(PQ1) Genomic characterization of mesenchymal stromal cells in Monoclonal Gammopathy of Undermined Significance (MGUS)
|
5R01CA205954-03
|
$703,249
|
$703,249
|
GHOBRIAL, IRENE
|
DANA-FARBER CANCER INST
|
|
(PQ1) Identifying and targeting human glioblastoma migrating in the peritumoral niche
|
5R01CA216054-02
|
$324,411
|
$324,411
|
HAYDEN GEPHART, MELANIE
|
STANFORD UNIVERSITY
|
|
(PQ1) Lipid Metabolism, Inflammation, and T cell Dysfunction in HIV-associated Cancer
|
5R01CA206483-02
|
$570,958
|
$570,958
|
EMU, BRINDA
|
YALE UNIVERSITY
|
|
(PQ1) The role of cell-to-cell variation in the penetrance of heritable mutant RAS hypodermal neoplasias
|
1R01CA219460-01A1
|
$397,573
|
$397,573
|
MENDENHALL, ALEXANDER
|
UNIVERSITY OF WASHINGTON
|
|
(PQ10) The impact of the gut microbiome on the anti-tumor effects of radiotherapy
|
1R01CA219871-01A1
|
$451,326
|
$451,326
|
FACCIABENE, ANDREA
|
UNIVERSITY OF PENNSYLVANIA
|
|
(PQ3) A functional genomic approach to identification and interpretation of germline-tumor genetic interactions
|
1R01CA227237-01
|
$686,519
|
$686,519
|
GUSEV, ALEXANDER
|
DANA-FARBER CANCER INST
|
|
(PQ3) Disruption of immune surveillance by aneuploidy and aberrant MHCII expression
|
5R01CA220009-02
|
$310,000
|
$310,000
|
ZANETTI, MAURIZIO
|
UNIVERSITY OF CALIFORNIA, SAN DIEGO
|
|
(PQ3) Immune epigenetic biomarkers of bladder cancer outcomes
|
5R01CA216265-02
|
$602,394
|
$602,394
|
CHRISTENSEN, BROCK
|
DARTMOUTH COLLEGE
|
|
(PQ4) Quantitative and multiplexed analysis of gene function in cancer in vivo
|
1R01CA231253-01
|
$471,700
|
$471,700
|
WINSLOW, MONTE
|
STANFORD UNIVERSITY
|
|
(PQ4A) Metabolic Plasticity of Pre-Malignant Cells During Tumor Progression
|
3R01CA194461-04S1
|
$7,505
|
$7,505
|
PARK, KWON-SIK
|
UNIVERSITY OF VIRGINIA
|
|
(PQ4A) Metabolic Plasticity of Pre-Malignant Cells During Tumor Progression
|
5R01CA194461-04
|
$334,291
|
$334,291
|
PARK, KWON-SIK
|
UNIVERSITY OF VIRGINIA
|
|
(PQ5) Consequences of imbalanced mitophagy and mitochondrial biogenesis in cancer
|
5R01CA216242-02
|
$319,238
|
$319,238
|
MACLEOD, KAY
|
UNIVERSITY OF CHICAGO
|
|
(PQ5) Contribution of mitochondrial pathways to metabolic heterogeneity in molecular subtypes of Diffuse Large B Cell Lymphoma
|
1R01CA219850-01A1
|
$558,022
|
$558,022
|
DANIAL, NIKA
|
DANA-FARBER CANCER INST
|
|
(PQ5) Effect of HIV infection on viral and host gene expression and antitumor immunity in Kaposi Sarcoma in Africa
|
5R01CA217138-02
|
$723,817
|
$723,817
|
WARREN, EDUS
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
(PQ5) Imaging mitochondrial heterogeneity in LKB1 mutant lung cancer
|
3R01CA208642-03S1
|
$71,387
|
$71,387
|
SHACKELFORD, DAVID
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
(PQ5) Imaging mitochondrial heterogeneity in LKB1 mutant lung cancer
|
3R01CA208642-03S2
|
$83,925
|
$83,925
|
SHACKELFORD, DAVID
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
(PQ5) Imaging mitochondrial heterogeneity in LKB1 mutant lung cancer
|
5R01CA208642-03
|
$352,275
|
$352,275
|
SHACKELFORD, DAVID
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
(PQ5) Informing anal neoplasia differences/similarities in HIV-serodiscordant individuals
|
3R21CA216830-02S1
|
$68,478
|
$68,478
|
SHIRAMIZU, BRUCE
|
UNIVERSITY OF HAWAII AT MANOA
|
|
(PQ5) Informing anal neoplasia differences/similarities in HIV-serodiscordant individuals
|
5R21CA216830-02
|
$192,500
|
$192,500
|
SHIRAMIZU, BRUCE
|
UNIVERSITY OF HAWAII AT MANOA
|
|
(PQ5) Mitochondria are endocellular symbionts that serve as targets for immune recognition
|
5R01CA206012-03
|
$403,884
|
$403,884
|
FACCIABENE, ANDREA
|
UNIVERSITY OF PENNSYLVANIA
|
|
(PQ5) Mitochondria in Leukemic Stem Cell Disease Progression
|
5R01CA205975-03
|
$386,619
|
$386,619
|
GHAFFARI, SAGHI
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
(PQ5) Role of Mitochondrial Division in Cancer Biology
|
5R01CA206005-03
|
$351,209
|
$351,209
|
CHIPUK, JERRY
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
(PQ8) Predicting immune-related toxicity in the adjuvant melanoma setting with checkpoint inhibition
|
1R01CA231295-01
|
$481,288
|
$481,288
|
OSMAN, IMAN
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
(PQ9) Developing EZH2 Degraders for Treating Triple-Negative Breast Cancer
|
1R01CA230854-01
|
$249,841
|
$249,841
|
JIN, JIAN
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
(PQA5) Dose and Mechanisms of Exercise in Breast Cancer Prevention
|
5R01CA179992-05
|
$648,503
|
$648,503
|
JONES, LEE
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
(PQB4) Stochastic Profiling of Functional Single-Cell States Within Solid Tumors
|
5R01CA194470-04
|
$446,627
|
$446,627
|
JANES, KEVIN
|
UNIVERSITY OF VIRGINIA
|
|
(PQC2) Localization as a determinant of cancer dormancy
|
5R01CA194596-04
|
$525,066
|
$525,066
|
LIN, CHARLES
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
00005I-0140 NCI-OD -- 8422873
|
271201800005I
|
$43,698
|
$43,698
|
N/A
|
KELLY SERVICES INC
|
|
00007I-4739 NCI-OD -- 8422873
|
271201500007I
|
$24,553
|
$24,553
|
N/A
|
KELLY SERVICES INC
|
|
00012I-0329 NCI-OD -- 8422873
|
271201800012I
|
$137,572
|
$137,572
|
N/A
|
KELLY SERVICES INC
|
|
01/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project
|
5U01DK048377-25
|
$39,000
|
$39,000
|
GADDE, KISHORE
|
LSU PENNINGTON BIOMEDICAL RESEARCH CTR
|
|
02/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project
|
5U01DK048381-25
|
$68,181
|
$68,181
|
EHRMANN, DAVID
|
UNIVERSITY OF CHICAGO
|
|
03/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project
|
5U01DK048468-25
|
$68,181
|
$68,181
|
FURLONG, KEVIN
|
THOMAS JEFFERSON UNIVERSITY
|
|
04/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project
|
5U01DK048434-25
|
$68,181
|
$68,181
|
GOLDBERG, RONALD
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
05/22 Diabetes Prevention Program Outcomes Study (DPPOS) - Phase 3 - Research Project
|
5U01DK048514-25
|
$68,181
|
$68,181
|
HAZUDA, HELEN
|
UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
|
|
06/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project
|
5U01DK048375-25
|
$68,181
|
$68,181
|
DABELEA, DANA
|
UNIVERSITY OF COLORADO DENVER
|
|
07/22 Diabetes Prevention Program Outcomes Study (DPPOS)Phase 3 - Research Project
|
5U01DK048437-25
|
$42,300
|
$42,300
|
MUNSHI, MEDHA
|
JOSLIN DIABETES CENTER
|
|
08/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project
|
5U01DK048413-25
|
$68,181
|
$68,181
|
KAHN, STEVEN
|
SEATTLE INST FOR BIOMEDICAL/CLINICAL RES
|
|
09/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project
|
5U01DK048411-25
|
$58,181
|
$58,181
|
DAGOGO-JACK, SAMUEL
|
UNIVERSITY OF TENNESSEE HEALTH SCI CTR
|
|
1/2 Southeast Partnership for Improving Research & Training in Cancer Health Disparities
|
5P20CA202920-02
|
$301,538
|
$301,538
|
MEADE, CATHY
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
1/2-Regional Geohealth Hub Centered in Peru-Peru
|
5U01TW010107-04
|
$224,955
|
$224,955
|
GONZALES, GUSTAVO
|
UNIVERSIDAD PERUANA CAYETANO HEREDIA
|
|
10/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3- Research Project
|
5U01DK048380-25
|
$68,181
|
$68,181
|
MOLITCH, MARK
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
Total relevant funding to Cancer for this search: $2,402,373,126
|